GILD vs PACK · P/E 18, rev $29.44B vs rev $368.9M
Gilead Sciences Inc (GILD) versus Ranpak Holdings Corp (PACK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Ranpak Holdings Corp (PACK) is a packaging & containers company listed on NYSE.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PACK revenue for 2024-12-31 was $368.9M. Net income was -$21.5M. Revenue was up 9.7% from 2023-12-31 to 2024-12-31. PACK currently screens at market cap $617.6M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PACK currently screens at market cap $617.6M.
Not investment advice. Open the GILD and PACK stock pages for the full models.
Not investment advice.